| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.017 | 16.151 | 11.332 | 19.191 | 20.298 | - | 0 | 0 | 0 | 0 |
| Total Income - EUR | 26.017 | 16.151 | 15.933 | 30.477 | 20.298 | - | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 32.255 | 17.685 | 14.649 | 25.277 | 17.433 | - | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -6.238 | -1.534 | 1.283 | 5.200 | 2.865 | - | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -7.019 | -1.893 | 1.124 | 4.895 | 2.623 | - | 0 | 0 | 0 | 0 |
| Employees | 3 | 1 | 1 | 2 | 2 | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Isabell & Biomixt Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 94 | 94 | 92 | 90 | 89 | - | 85 | 85 | 85 | 84 |
| Current Assets | 47.142 | 47.694 | 50.006 | 57.405 | 61.696 | - | 58.457 | 58.638 | 58.460 | 58.133 |
| Inventories | 40.865 | 42.062 | 44.875 | 51.900 | 54.135 | - | 51.931 | 52.092 | 51.934 | 51.644 |
| Receivables | 5.340 | 5.084 | 5.051 | 5.487 | 5.628 | - | 5.402 | 5.418 | 5.402 | 5.372 |
| Cash | 937 | 548 | 80 | 17 | 1.933 | - | 1.124 | 1.127 | 1.124 | 1.118 |
| Shareholders Funds | -18.907 | -20.607 | -19.134 | -13.888 | -10.996 | - | -11.239 | -11.274 | -11.240 | -11.177 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | 40 | 41 | 40 | 40 |
| Debts | 67.217 | 69.458 | 70.278 | 72.409 | 73.787 | - | 70.746 | 70.965 | 70.750 | 70.354 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Isabell & Biomixt Srl